If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
33
|
9
|
172
|
99
|
30
|
2
|
3
|
319
|
Gene and significance breakdown #
Total genes and gene combinations: 6
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
PINK1
|
32
|
9
|
160
|
94
|
20
|
0 |
3
|
291
|
MIR6084, PINK1
|
1
|
0 |
11
|
4
|
1
|
0 |
0 |
16
|
DDOST, PINK1
|
0 |
0 |
0 |
1
|
9
|
0 |
0 |
9
|
AKR7A2, AKR7A3, AKR7L, ALDH4A1, ALPL, C1QA, C1QB, C1QC, CAMK2N1, CAPZB, CDA, CDC42, CELA3A, CELA3B, DDOST, ECE1, EIF4G3, EMC1, EPHA8, FAM43B, HP1BP3, HSPG2, HTR6, IFFO2, KIF17, LDLRAD2, MICOS10, MICOS10-NBL1, MRTO4, MUL1, NBL1, NBPF3, OTUD3, PINK1, PLA2G2A, PLA2G2C, PLA2G2D, PLA2G2E, PLA2G2F, PLA2G5, RAP1GAP, RNF186, SH2D5, SLC66A1, TMCO4, UBR4, UBXN10, USP48, VWA5B1, WNT4, ZBTB40
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
MT-ND5
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
MT-ND6
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
23
|
5
|
107
|
91
|
22
|
0 |
0 |
248
|
Illumina Laboratory Services, Illumina
|
1
|
0 |
62
|
7
|
15
|
0 |
0 |
85
|
Fulgent Genetics, Fulgent Genetics
|
1
|
0 |
22
|
5
|
2
|
0 |
0 |
30
|
OMIM
|
12
|
0 |
0 |
0 |
0 |
2
|
0 |
14
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
|
1
|
1
|
4
|
0 |
0 |
0 |
0 |
6
|
Baylor Genetics
|
1
|
0 |
3
|
0 |
0 |
0 |
0 |
4
|
Revvity Omics, Revvity
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
4
|
0 |
0 |
4
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
|
0 |
0 |
0 |
0 |
3
|
0 |
0 |
3
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
2
|
1
|
0 |
0 |
0 |
0 |
3
|
Centogene AG - the Rare Disease Company
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
GeneReviews
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
Athena Diagnostics
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Centre for Genetic Disorders, Banaras Hindu University
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Genetics and Molecular Pathology, SA Pathology
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Molecular Genetics, Royal Melbourne Hospital
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Department of Human Genetics, Hannover Medical School
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Department of Neurology, Xijing Hospital, Fourth Military Medical University
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.